SCHEMBL18823290

SCHEMBL18823290

CCC(C)(C)C(=O)CCCCCN

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAOX Q6QHF9 2/20 0.50
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ PLG P00747 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ CYP2D6 P10635 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.42
▸ BLM P54132 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ FAAH O00519 8/20 0.41
▸ CES1 P23141 5/20 0.41
▸ CES2 O00748 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18768794 0.98 PAOX (0.46) PAOXMEN1KMT2AALDH1A1PLG
SCHEMBL21666663 0.83 FAAH (0.59) MEN1KMT2AALDH1A1ALOX15FAAH
SCHEMBL8898816 0.83 FAAH (0.59) MEN1KMT2AALDH1A1ALOX15FAAH
SCHEMBL13596603 0.83 FAAH (0.59) MEN1KMT2AALDH1A1ALOX15FAAH
SCHEMBL21257214 0.83 FAAH (0.59) MEN1KMT2AALDH1A1ALOX15FAAH
SCHEMBL23386452 0.83 FAAH (0.59) MEN1KMT2AALDH1A1ALOX15FAAH
SCHEMBL21422317 0.83 FAAH (0.59) MEN1KMT2AALDH1A1ALOX15FAAH
SCHEMBL22525181 0.83 FAAH (0.59) MEN1KMT2AALDH1A1ALOX15FAAH
SCHEMBL21129894 0.82 RIPK1 (0.33) PAOXMEN1KMT2AALDH1A1THRB
SCHEMBL18906116 0.82 FAAH (0.41) MEN1KMT2AALDH1A1LMNAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200385402-A1 Maytansinoid Derivatives, Conjugates Thereof, and Methods of Use REGENERON PHARMACEUTICALS, INC. 2020-12-10 — — US disclosed
US-10772971-B2 Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates Mersana Therpeutics, Inc. (US) 2020-09-15 — — US disclosed
US-20170119896-A1 TERMINALLY MODIFIED POLYMERS AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2017-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200385402-A1 Maytansinoid Derivatives, Conjugates Thereof, and Methods of Use SLC10A1, HNMT, OGFR PAOX 1640/4885MEN1 876/4885KMT2A 3577/4885
US-10772971-B2 Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates PBRM1, BRAP, STAMBP PAOX 2368/4885MEN1 4613/4885KMT2A 2013/4885
US-20170119896-A1 TERMINALLY MODIFIED POLYMERS AND CONJUGATES THEREOF MALT1, ALG1, PRMT3 PAOX 2650/4885MEN1 1055/4885KMT2A 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback